Rhythm Pharmaceuticals Insider Trades
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 50 · $42.26M
- Shares bought / sold
- 0 / 383.28K
- Net activity
- Net selling $42.3 million
Rhythm Pharmaceuticals insider activity
Over the last 12 months, Rhythm Pharmaceuticals insiders reported 90 transactions on SEC Form 4: 0 open-market purchases and 50 sales. Insiders bought $0 and sold $42.3 million worth of stock, for net insider selling of $42.3 million. The largest seller was Lee Jennifer Kayden, with $8.9 million in reported sales.
The most recent filing shows Shulman Joseph (Chief Technical Officer) reporting a transaction in 1,961 shares at $6.80 on Nov 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RYTM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RYTM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 18, 2026 | Shulman JosephChief Technical Officer | Sale | 45,921 | $5.51M | Form 4 |
| Nov 18, 2026 | Shulman JosephChief Technical Officer | Option exercise | 9,374 | $531.41K | Form 4 |
| Nov 18, 2026 | Shulman JosephChief Technical Officer | Option exercise | 24,944 | $1.23M | Form 4 |
| Nov 18, 2026 | Shulman JosephChief Technical Officer | Option exercise | 4,188 | $114.54K | Form 4 |
| Nov 18, 2026 | Shulman JosephChief Technical Officer | Option exercise | 1,961 | $13.33K | Form 4 |
| Nov 17, 2026 | JEAN CHRISTOPHEDirector | Sale | 2,500 | $287.50K | Form 4 |
| Nov 17, 2026 | JEAN CHRISTOPHEDirector | Sale | 2,500 | $275.00K | Form 4 |
| Nov 17, 2026 | JEAN CHRISTOPHEDirector | Sale | 5,000 | $534.05K | Form 4 |
| Nov 17, 2026 | JEAN CHRISTOPHEDirector | Option exercise | 10,000 | $348.90K | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Sale | 2,300 | $241.94K | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Sale | 1,817 | $189.96K | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Sale | 8,698 | $899.63K | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Sale | 30,746 | $3.15M | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Sale | 6,439 | $655.15K | Form 4 |
| Sep 14, 2026 | Meeker David PPresident and CEO | Option exercise | 50,000 | $302.50K | Form 4 |
| Aug 31, 2026 | Smith Hunter CChief Financial Officer | Sale | 28,188 | $2.99M | Form 4 |
| Aug 31, 2026 | Smith Hunter CChief Financial Officer | Sale | 11,514 | $1.21M | Form 4 |
| Aug 31, 2026 | Smith Hunter CChief Financial Officer | Sale | 23,072 | $2.41M | Form 4 |
| Aug 31, 2026 | Smith Hunter CChief Financial Officer | Option exercise | 57,187 | $1.47M | Form 4 |
| Aug 13, 2026 | Lee Jennifer KaydenEVP, Head of North America | Sale | 75,834 | $8.90M | Form 4 |
| Aug 13, 2026 | Lee Jennifer KaydenEVP, Head of North America | Option exercise | 21,601 | $146.89K | Form 4 |
| Aug 13, 2026 | Lee Jennifer KaydenEVP, Head of North America | Option exercise | 35,000 | $850.15K | Form 4 |
| Aug 13, 2026 | Shulman JosephChief Technical Officer | Sale | 5,079 | $608.21K | Form 4 |
| Aug 13, 2026 | Shulman JosephChief Technical Officer | Option exercise | 2,024 | $13.76K | Form 4 |
| Aug 13, 2026 | Garfield AlastairChief Scientific Officer | Sale | 800 | $95.34K | Form 4 |
| Aug 13, 2026 | Garfield AlastairChief Scientific Officer | Sale | 3,400 | $402.17K | Form 4 |
| Aug 13, 2026 | Garfield AlastairChief Scientific Officer | Sale | 1,556 | $182.17K | Form 4 |
| Aug 13, 2026 | Garfield AlastairChief Scientific Officer | Sale | 2,007 | $233.03K | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 17,319 | $2.03M | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 18,208 | $2.12M | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 14,568 | $1.68M | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 3,605 | $413.48K | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 1,000 | $112.86K | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Sale | 2,300 | $257.14K | Form 4 |
| Aug 12, 2026 | Mazabraud YannEVP, Head of International | Option exercise | 46,625 | $317.05K | Form 4 |
| Jul 1, 2026 | Garfield AlastairChief Scientific Officer | Tax withholding | 2,150 | $237.38K | Form 4 |
| Jul 1, 2026 | Garfield AlastairChief Scientific Officer | Option exercise | 4,445 | — | Form 4 |
| Jun 23, 2026 | GOOD JENNIFER LDirector | Option exercise | 4,712 | — | Form 4 |
| Jun 23, 2026 | Arbuckle Stuart ADirector | Option exercise | 4,712 | — | Form 4 |
| Jun 23, 2026 | TETRAULT LYNN A.Director | Option exercise | 4,712 | — | Form 4 |
| Jun 23, 2026 | MCGIRR DAVID W JDirector | Option exercise | 4,712 | — | Form 4 |
| Jun 23, 2026 | JEAN CHRISTOPHEDirector | Option exercise | 4,712 | — | Form 4 |
| Jun 22, 2026 | TETRAULT LYNN A.Director | Sale | 37,000 | $3.71M | Form 4 |
| Jun 22, 2026 | TETRAULT LYNN A.Director | Option exercise | 37,000 | $1.05M | Form 4 |
| May 18, 2026 | Smith Hunter CChief Financial Officer | Option exercise | 3,000 | $53.61K | Form 4 |
| May 15, 2026 | German Christopher PaulCorporate Controller & CAO | Sale | 4,643 | $428.13K | Form 4 |
| May 15, 2026 | German Christopher PaulCorporate Controller & CAO | Option exercise | 1,406 | $25.27K | Form 4 |
| May 15, 2026 | German Christopher PaulCorporate Controller & CAO | Option exercise | 1,349 | $66.41K | Form 4 |
| May 15, 2026 | German Christopher PaulCorporate Controller & CAO | Option exercise | 1,687 | $95.64K | Form 4 |
| Apr 1, 2026 | Mazabraud YannEVP, Head of International | Option exercise | 12,875 | — | Form 4 |
| Mar 12, 2026 | Mathers Edward TDirector | other | 4,199 | — | Form 4 |
| Mar 4, 2026 | German Christopher PaulCorporate Controller & CAO | Sale | 5,614 | $502.79K | Form 4 |
| Mar 4, 2026 | German Christopher PaulCorporate Controller & CAO | Option exercise | 1,500 | $26.95K | Form 4 |
| Mar 2, 2026 | Smith Hunter CChief Financial Officer | Option exercise | 6,099 | $41.47K | Form 4 |
| Mar 2, 2026 | Mathers Edward TDirector | other | 4,198 | — | Form 4 |
| Mar 1, 2026 | German Christopher PaulCorporate Controller & CAO | Tax withholding | 342 | $32.47K | Form 4 |
| Mar 1, 2026 | German Christopher PaulCorporate Controller & CAO | Option exercise | 1,162 | — | Form 4 |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sale | 585 | $60.42K | Form 4 |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sale | 800 | $81.68K | Form 4 |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,692 | $170.75K | Form 4 |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,308 | $131.15K | Form 4 |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sale | 200 | $20.77K | Form 4 |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,069 | $110.11K | Form 4 |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sale | 900 | $91.53K | Form 4 |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sale | 200 | $20.10K | Form 4 |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,200 | $119.30K | Form 4 |
| Feb 14, 2026 | Mazabraud YannEVP, Head of International | Option exercise | 10,000 | — | Form 4 |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sale | 100 | $10.01K | Form 4 |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sale | 800 | $79.19K | Form 4 |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sale | 400 | $39.07K | Form 4 |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sale | 292 | $28.11K | Form 4 |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sale | 100 | $10.09K | Form 4 |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sale | 400 | $39.77K | Form 4 |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sale | 2,266 | $222.91K | Form 4 |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sale | 100 | $10.48K | Form 4 |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sale | 700 | $72.57K | Form 4 |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,913 | $196.38K | Form 4 |
| Feb 5, 2026 | Smith Hunter CChief Financial Officer | Sale | 3,381 | $358.60K | Form 4 |
| Feb 4, 2026 | Smith Hunter CChief Financial Officer | Sale | 747 | $80.43K | Form 4 |
| Feb 4, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,000 | $106.60K | Form 4 |
| Feb 4, 2026 | Smith Hunter CChief Financial Officer | Sale | 1,500 | $157.12K | Form 4 |
| Feb 1, 2026 | Meeker David PPresident and CEO | Tax withholding | 31,522 | $3.44M | Form 4 |
| Feb 1, 2026 | Meeker David PPresident and CEO | Option exercise | 68,713 | — | Form 4 |
| Feb 1, 2026 | Lee Jennifer KaydenEVP, Head of North America | Tax withholding | 9,237 | $1.01M | Form 4 |
| Feb 1, 2026 | Lee Jennifer KaydenEVP, Head of North America | Option exercise | 22,612 | — | Form 4 |
| Feb 1, 2026 | Smith Hunter CChief Financial Officer | Tax withholding | 10,750 | $1.17M | Form 4 |
| Feb 1, 2026 | Smith Hunter CChief Financial Officer | Option exercise | 26,000 | — | Form 4 |
| Feb 1, 2026 | Mazabraud YannEVP, Head of International | Option exercise | 5,500 | — | Form 4 |
| Feb 1, 2026 | Shulman JosephChief Technical Officer | Tax withholding | 6,507 | $709.20K | Form 4 |
| Feb 1, 2026 | Shulman JosephChief Technical Officer | Option exercise | 16,968 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4